146 related articles for article (PubMed ID: 38444445)
21. A Pilot Study to Evaluate the Acceptability of Using a Smart Pillbox to Enhance Medication Adherence Among Primary Care Patients.
Choi EPH
Int J Environ Res Public Health; 2019 Oct; 16(20):. PubMed ID: 31627440
[TBL] [Abstract][Full Text] [Related]
22. Effect of mobile health reminders on tuberculosis treatment outcomes in Shanghai, China: A prospective cohort study.
Wu Z; Lu L; Li Y; Chen J; Zhang Z; Ning C; Yuan Z; Pan Q; Shen X; Zhang W
Front Public Health; 2023; 11():923319. PubMed ID: 37181717
[TBL] [Abstract][Full Text] [Related]
23. Feasibility of Customized Pillboxes to Enhance Medication Adherence: A Randomized Controlled Trial.
Schwartz J; Ballard DH
Arch Phys Med Rehabil; 2022 Dec; 103(12):2288-2295. PubMed ID: 35430239
[TBL] [Abstract][Full Text] [Related]
24. Digital adherence technologies for the management of tuberculosis therapy: mapping the landscape and research priorities.
Subbaraman R; de Mondesert L; Musiimenta A; Pai M; Mayer KH; Thomas BE; Haberer J
BMJ Glob Health; 2018; 3(5):e001018. PubMed ID: 30364330
[TBL] [Abstract][Full Text] [Related]
25. Acceptability, Usefulness, and Ease of Use of an Enhanced Video Directly Observed Treatment System for Supporting Patients With Tuberculosis in Kampala, Uganda: Explanatory Qualitative Study.
Sekandi JN; McDonald A; Nakkonde D; Zalwango S; Kasiita V; Kaggwa P; Kakaire R; Atuyambe L; Buregyeya E
JMIR Form Res; 2023 Nov; 7():e46203. PubMed ID: 37948121
[TBL] [Abstract][Full Text] [Related]
26. Mobile Health for Tuberculosis Management in South India: Is Video-Based Directly Observed Treatment an Acceptable Alternative?
Kumar AA; De Costa A; Das A; Srinivasa GA; D'Souza G; Rodrigues R
JMIR Mhealth Uhealth; 2019 Apr; 7(4):e11687. PubMed ID: 30942696
[TBL] [Abstract][Full Text] [Related]
27. An electronic pillbox intervention designed to improve medication safety during care transitions: challenges and lessons learned regarding implementation and evaluation.
Shahani A; Nieva HR; Czado K; Shannon E; Gaetani R; Gresham M; Garcia JC; Ganesan H; Cerciello E; Dave J; Jain R; Schnipper JL
BMC Health Serv Res; 2022 Oct; 22(1):1304. PubMed ID: 36309744
[TBL] [Abstract][Full Text] [Related]
28. Implementation bottlenecks of real time medication monitoring (evriMED) for improving adherence to anti-TB drugs among people with tuberculosis in Kilimanjaro, Tanzania.
Anenmose Maro R; Mtenga A; Mtesha B; Wilhelm K; Lekashingo N; Sumari-de Boer M; Ngowi K
J Clin Tuberc Other Mycobact Dis; 2024 Feb; 34():100409. PubMed ID: 38225942
[TBL] [Abstract][Full Text] [Related]
29. Explaining Differences in the Acceptability of 99DOTS, a Cell Phone-Based Strategy for Monitoring Adherence to Tuberculosis Medications: Qualitative Study of Patients and Health Care Providers.
Thomas BE; Kumar JV; Onongaya C; Bhatt SN; Galivanche A; Periyasamy M; Chiranjeevi M; Khandewale AS; Ramachandran G; Shah D; Haberer JE; Mayer KH; Subbaraman R
JMIR Mhealth Uhealth; 2020 Jul; 8(7):e16634. PubMed ID: 32735220
[TBL] [Abstract][Full Text] [Related]
30. Evaluating the effect of short-course rifapentine-based regimens with or without enhanced behaviour-targeted treatment support on adherence and completion of treatment for latent tuberculosis infection among adults in the UK (RID-TB: Treat): protocol for an open-label, multicentre, randomised controlled trial.
Rangaka MX; Hamada Y; Duong T; Bern H; Calvert J; Francis M; Clarke AL; Ghanouni A; Layton C; Hack V; Owen-Powell E; Surey J; Sanders K; Booth HL; Crook A; Griffiths C; Horne R; Kunst H; Lipman M; Mandelbaum M; White PJ; Zenner D; Abubakar I
BMJ Open; 2022 Sep; 12(9):e057717. PubMed ID: 36691120
[TBL] [Abstract][Full Text] [Related]
31. Patient-centered mobile tuberculosis treatment support tools (TB-TSTs) to improve treatment adherence: A pilot randomized controlled trial exploring feasibility, acceptability and refinement needs.
Iribarren SJ; Milligan H; Chirico C; Goodwin K; Schnall R; Telles H; Iannizzotto A; Sanjurjo M; Lutz BR; Pike K; Rubinstein F; Rhodehamel M; Leon D; Keyes J; Demiris G
Lancet Reg Health Am; 2022 Sep; 13():. PubMed ID: 36061038
[TBL] [Abstract][Full Text] [Related]
32. "I Wish to Continue Receiving the Reminder Short Messaging Service": A Mixed Methods Study on the Acceptability of Digital Adherence Tools Among Adults Living with HIV on Antiretroviral Treatment in Tanzania.
Ngowi K; Pima F; Mmbaga BT; Aarnoutse RE; Reiss P; Nieuwkerk PT; Sprangers M; Sumari-de Boer M
Patient Prefer Adherence; 2021; 15():559-568. PubMed ID: 33727801
[TBL] [Abstract][Full Text] [Related]
33. Stakeholders' Perceptions of Benefits of and Barriers to Using Video-Observed Treatment for Monitoring Patients With Tuberculosis in Uganda: Exploratory Qualitative Study.
Sekandi JN; Kasiita V; Onuoha NA; Zalwango S; Nakkonde D; Kaawa-Mafigiri D; Turinawe J; Kakaire R; Davis-Olwell P; Atuyambe L; Buregyeya E
JMIR Mhealth Uhealth; 2021 Oct; 9(10):e27131. PubMed ID: 34704961
[TBL] [Abstract][Full Text] [Related]
34. Methodology and feasibility of a 3D printed assistive technology intervention.
Schwartz JK; Fermin A; Fine K; Iglesias N; Pivarnik D; Struck S; Varela N; Janes WE
Disabil Rehabil Assist Technol; 2020 Feb; 15(2):141-147. PubMed ID: 30663439
[TBL] [Abstract][Full Text] [Related]
35. Digital monitoring technologies could enhance tuberculosis medication adherence in Uganda: Mixed methods study.
Musiimenta A; Tumuhimbise W; Mugaba AT; Muzoora C; Armstrong-Hough M; Bangsberg D; Davis JL; Haberer JE
J Clin Tuberc Other Mycobact Dis; 2019 Dec; 17():100119. PubMed ID: 31788561
[TBL] [Abstract][Full Text] [Related]
36. Feasibility and acceptability pilot of video-based direct observed treatment (vDOT) for supporting antitubercular treatment in South India: a cohort study.
Rodrigues R; Varghese SS; Mahrous M; Ananthaneni Kumar A; Ahmed MN; D'Souza G
BMJ Open; 2023 May; 13(5):e065878. PubMed ID: 37247959
[TBL] [Abstract][Full Text] [Related]
37. Study protocol and implementation details for a pragmatic, stepped-wedge cluster randomised trial of a digital adherence technology to facilitate tuberculosis treatment completion.
Crowder R; Kityamuwesi A; Kiwanuka N; Lamunu M; Namale C; Tinka LK; Nakate AS; Ggita J; Turimumahoro P; Babirye D; Oyuku D; Berger CA; Tucker A; Patel D; Sammann A; Dowdy D; Stavia T; Cattamanchi A; Katamba A
BMJ Open; 2020 Nov; 10(11):e039895. PubMed ID: 33247012
[TBL] [Abstract][Full Text] [Related]
38. Can digital adherence technologies reduce inequity in tuberculosis treatment success? Evidence from a randomised controlled trial.
Boutilier JJ; Yoeli E; Rathauser J; Owiti P; Subbaraman R; Jónasson JO
BMJ Glob Health; 2022 Dec; 7(12):. PubMed ID: 36455988
[TBL] [Abstract][Full Text] [Related]
39. Acceptability of a Mobile Phone Support Tool (Call for Life Uganda) for Promoting Adherence to Antiretroviral Therapy Among Young Adults in a Randomized Controlled Trial: Exploratory Qualitative Study.
Twimukye A; Bwanika Naggirinya A; Parkes-Ratanshi R; Kasirye R; Kiragga A; Castelnuovo B; Wasswa J; Nabaggala MS; Katabira E; Lamorde M; King RL
JMIR Mhealth Uhealth; 2021 Jun; 9(6):e17418. PubMed ID: 34121665
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
